• Medicine
• Published in Respiratory investigation 2016
• DOI:10.1016/j.resinv.2016.03.001

Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.

@article{Nakashita2016PossibleEO,
  title={Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.},
  author={Tamao Nakashita and Katsutoshi Ando and Kazuhisa Takahashi and Shinji Motojima},
  journal={Respiratory investigation},
  year={2016},
  volume={54 5},
  pages={
          376-9
        }
}

• Tamao Nakashita, Katsutoshi Ando, +1 author Shinji Motojima

Rheumatoid arthritis (RA) is a generally progressive, systemic autoimmune condition characterized by chronic erosive synovitis. Interstitial lung disease (ILD) is a common extraarticular manifestation of RA and is substantially more likely to cause morbidity and mortality [1]. Several diseasemodifying anti-rheumatic drugs and numerous biological therapies for RA have been widely used. These treatments, targeted at alleviating symptoms and preventing joint destruction, represent an important… CONTINUE READING

View on PubMed

Alternate Sources

Save to Library

Create Alert

Cite